Skyscape Web Viewer : The Washington Manual of Medical Therapeutics : Main Index

View All
Multidose AC (MDAC)
Multidose charcoal
Multidrug anti-TB treatment regimens
Multidrug-resistant tuberculosis
Multifocal atrial tachycardia (MAT)
Multiple myeloma (MM)
Multiple sclerosis (MS)
Musculoskeletal involvement diffuse scleroderma polyarteritis nodosa (PAN)
MuSK antibodies
Myasthenia gravis (MG)
Myasthenic crisis
Mycobacterium avium complex (MAC) infection
Mycobacterium leprae
Mycobacterium tuberculosis Mycobacterium Tuberculosis Tuberculosis
Mycophenolate mofetil for systemic lupus erythematosus (SLE) lupus nephritis (LN) polymyositis (PM) Synthetic Dmards
Mycophenolic acid (MPA)
Mycoses
Myelodysplastic syndromes (MDS) Myelodysplastic Syndrome Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes
Myeloproliferative neoplasms
Myeloproliferative variants
Myelotoxicity
Myocardial infarction (MI)
Myocardial ischemia
Myocardial perfusion imaging (MPI)
Myocarditis
Myopathies
Myosin loss myopathy
Myositis-associated antibodies (MAAs)
Myositis-Specific Antibodies (Msa)
Myositis-specific antibodies (MSAs) Idiopathic Inflammatory Myopathies Myositis-Specific Antibodies (Msa)